关注
Ken Namikawa
Ken Namikawa
Japanese foundation for cancer research, Gastroenterologist
在 jfcr.or.jp 的电子邮件经过验证
标题
引用次数
引用次数
年份
Detecting early gastric cancer: Comparison between the diagnostic ability of convolutional neural networks and endoscopists
Y Ikenoyama, T Hirasawa, M Ishioka, K Namikawa, S Yoshimizu, ...
Digestive Endoscopy 33 (1), 141-150, 2021
1382021
Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions
C Yasue, A Chino, M Takamatsu, K Namikawa, D Ide, S Saito, M Igarashi, ...
Journal of gastroenterology 54, 708-717, 2019
812019
Performance of a computer-aided diagnosis system in diagnosing early gastric cancer using magnifying endoscopy videos with narrow-band imaging (with videos)
Y Horiuchi, T Hirasawa, N Ishizuka, Y Tokai, K Namikawa, S Yoshimizu, ...
Gastrointestinal endoscopy 92 (4), 856-865. e1, 2020
692020
Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer
S Yagi, T Wakatsuki, N Yamamoto, K Chin, D Takahari, M Ogura, ...
Gastric Cancer 22, 518-525, 2019
572019
Utilizing artificial intelligence in endoscopy: a clinician’s guide
K Namikawa, T Hirasawa, T Yoshio, J Fujisaki, T Ozawa, S Ishihara, ...
Expert review of gastroenterology & hepatology 14 (8), 689-706, 2020
432020
Artificial intelligence-based diagnostic system classifying gastric cancers and ulcers: comparison between the original and newly developed systems
K Namikawa, T Hirasawa, K Nakano, Y Ikenoyama, M Ishioka, S Shiroma, ...
Endoscopy 52 (12), 1077-1083, 2020
412020
Current status and future perspective of artificial intelligence applications in endoscopic diagnosis and management of gastric cancer
T Hirasawa, Y Ikenoyama, M Ishioka, K Namikawa, Y Horiuchi, ...
Digestive Endoscopy 33 (2), 263-272, 2021
262021
Ability of artificial intelligence to detect T1 esophageal squamous cell carcinoma from endoscopic videos and the effects of real-time assistance
S Shiroma, T Yoshio, Y Kato, Y Horie, K Namikawa, Y Tokai, S Yoshimizu, ...
Scientific Reports 11 (1), 7759, 2021
242021
Is proximal gastrectomy indicated for locally advanced cancer in the upper third of the stomach?
M Ri, K Kumagai, K Namikawa, S Atsumi, M Hayami, R Makuuchi, S Ida, ...
Annals of Gastroenterological Surgery 5 (6), 767-775, 2021
172021
Histopathologic analysis of signet-ring cell carcinoma in situ in patients with hereditary diffuse gastric cancer
Y Tsugeno, K Nakano, T Nakajima, K Namikawa, M Takamatsu, ...
The American Journal of Surgical Pathology 44 (9), 1204-1212, 2020
162020
Long‐term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a‐muscularis mucosae and T1b‐submucosa by endoscopic resection followed by …
S Naito, T Yoshio, A Ishiyama, T Tsuchida, J Tokura, K Namikawa, ...
Digestive Endoscopy 34 (4), 793-804, 2022
152022
Incidence of metachronous cancer after endoscopic submucosal dissection: a comparison between undifferentiated-type and differentiated-type early gastric cancer
M Ishioka, T Yoshio, Y Miyamoto, K Namikawa, Y Tokai, S Yoshimizu, ...
Gastrointestinal Endoscopy 93 (3), 557-564. e1, 2021
122021
Clinical outcomes of endoscopic resection of preoperatively diagnosed non-circumferential T1a-muscularis mucosae or T1b-submucosa 1 esophageal squamous cell carcinoma
K Namikawa, T Yoshio, S Yoshimizu, A Ishiyama, T Tsuchida, Y Tokai, ...
Scientific Reports 11 (1), 6554, 2021
112021
Clinical characteristics and long‐term prognosis of type 1 gastric neuroendocrine tumors in a large Japanese national cohort
K Namikawa, T Kamada, J Fujisaki, Y Sato, T Murao, T Chiba, Y Kaizaki, ...
Digestive Endoscopy, 2023
82023
Artificial intelligence diagnostic system predicts multiple Lugol-voiding lesions in the esophagus and patients at high risk for esophageal squamous cell carcinoma
Y Ikenoyama, T Yoshio, J Tokura, S Naito, K Namikawa, Y Tokai, ...
Endoscopy 53 (11), 1105-1113, 2021
82021
Diagnostic performance in gastric cancer is higher using endocytoscopy with narrow-band imaging than using magnifying endoscopy with narrow-band imaging
Y Horiuchi, T Hirasawa, N Ishizuka, H Hatamori, Y Ikenoyama, J Tokura, ...
Gastric Cancer 24, 417-427, 2021
82021
Usefulness of the l‐type Wako Helicobacter pylori antibody J test
Y Tokai, J Fujisaki, N Ishizuka, H Osumi, K Namikawa, S Yoshimizu, ...
JGH Open 5 (6), 673-678, 2021
62021
Detection of multiple intramucosal signet-ring cell carcinomas by white-light endoscopy and magnifying endoscopy with narrow-band imaging in a hereditary diffuse gastric cancer …
K Namikawa, H Kawachi, Y Tsugeno, T Nakajima, J Fujisaki
VideoGIE 6 (4), 163-166, 2021
62021
Genomic features of Helicobacter pylori‐naïve diffuse‐type gastric cancer
K Namikawa, N Tanaka, Y Ota, M Takamatsu, M Kosugi, Y Tokai, ...
The Journal of Pathology 258 (3), 300-311, 2022
52022
Risk factors for lymph node metastasis and indication of local resection in duodenal neuroendocrine tumors
E Nakao, K Namikawa, T Hirasawa, K Nakano, Y Tokai, S Yoshimizu, ...
JGH Open 6 (3), 189-195, 2022
52022
系统目前无法执行此操作,请稍后再试。
文章 1–20